Form 4: LifeStance Health Executive Sells Shares to Cover Tax Obligations
SEC Form 4 Filing
A LifeStance Health Group executive sold 10,540 shares of common stock to cover tax obligations related to vesting restricted stock units.
Summary
- Lisa K. Miller, an Executive Vice President at LifeStance Health Group, sold 10,540 shares of common stock on November 13, 2024.
- The sale was executed at a price of $7.45 per share.
- This transaction was not a discretionary trade but rather a 'sell to cover' transaction to satisfy tax withholding obligations related to the vesting of restricted stock units.
- Following the transaction, Ms. Miller beneficially owns 288,994 shares of LifeStance Health Group stock.
Sentiment
Score: 5
Explanation: The document reflects a routine transaction for tax purposes and does not indicate any positive or negative sentiment towards the company's performance or future prospects.
Management Comments
- The sale was made to satisfy tax withholding obligations through a 'sell to cover' transaction and does not represent a discretionary trade by the Reporting Person.
Industry Context
Executive stock sales are a common occurrence, especially when restricted stock units vest, and are often used to cover tax liabilities. This is a routine transaction and does not necessarily indicate a change in the executive's outlook on the company.
Comparison to Industry Standards
- Executive stock sales to cover tax obligations are a standard practice across publicly traded companies.
- Similar transactions are regularly reported by executives at companies like Teladoc Health (TDOC) and Amwell (AMWL), which are also in the telehealth space.
- The volume of shares sold is relatively small compared to the total shares outstanding, and is not unusual for a vesting event.
Stakeholder Impact
- The transaction has a minimal impact on shareholders as it is a routine sale to cover tax obligations.
- The sale does not affect the company's operations or financial health.
Key Dates
| Date | Description |
|---|---|
| 11/13/2024 | Date of the stock sale transaction. |
| 11/15/2024 | Date the Form 4 was signed. |
Keywords
LifeStance Health Group, stock sale, executive transaction, Form 4, insider trading, tax obligations, restricted stock units, LFST
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.